Licochalcone A
Latest Information Update: 24 Oct 2021
At a glance
- Originator Beiersdorf; University of Iowa
- Class Anti-inflammatories; Antimalarials; Flavonoids; Propiophenones; Skin disorder therapies
- Mechanism of Action Antioxidants; Cytokine inhibitors; Cytokine modulators; Eicosanoid receptor antagonists; Free radical scavengers; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Rosacea; Skin disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Rosacea in Germany (Topical, Lotion)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Rosacea in USA (Topical, Lotion)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Skin-disorders in Germany (Topical, Lotion)